ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,038Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 278

$1M Total Retail Price of All Prescriptions

Rank: 30 out of 278

470 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 470 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

24% of this provider’s 470 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 14,134 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
HYDROCODONE-ACETAMINOPHEN 1,026 605 S3 1 1
LISINOPRIL 606 482 2 5
FUROSEMIDE 547 472 3 6
OMEPRAZOLE 495 406 4 3
LEVOTHYROXINE SODIUM 464 411 5 2
AMLODIPINE BESYLATE 450 392 6 7
SIMVASTATIN 413 366 7 4
CARVEDILOL 398 328 8 23
POTASSIUM CHLORIDE 387 322 9 17
METOPROLOL TARTRATE 320 308 10 9
METFORMIN HCL 312 254 11 8
NEXIUM 270 206 12 14
CEFUROXIME 268 196 13 86
METOPROLOL SUCCINATE 233 220 14 10
WARFARIN SODIUM 227 209 15 11
CLOPIDOGREL 225 199 16 20
CITALOPRAM HBR 215 161 17 21
NAMENDA 213 193 18 48
TRAMADOL HCL 206 158 19 22
LOSARTAN POTASSIUM 200 158 20 24
ATORVASTATIN CALCIUM 199 172 21 13
DONEPEZIL HCL 199 186 21 29
SERTRALINE HCL 184 156 23 25
HYDROCHLOROTHIAZIDE 182 151 24 15
GABAPENTIN 181 126 25 12
ATENOLOL 178 135 26 18
CYMBALTA 169 129 27 41
TAMSULOSIN HCL 149 140 28 32
JANUVIA 142 104 29 53
ESCITALOPRAM OXALATE 138 94 30 63
PLAVIX 137 121 31 30
GLIPIZIDE 137 121 31 55
RANITIDINE HCL 134 89 33 27
LEVOFLOXACIN 133 90 34 66
DIOVAN 129 112 35 43
BENICAR 128 91 36 134
TRAZODONE HCL 125 112 37 47
ZOLPIDEM TARTRATE 121 77 38 26
DIGOXIN 119 115 39 40
PROAIR HFA 117 44 40 34
TORSEMIDE 113 88 41 97
GLYBURIDE 110 88 R 42 88
ALBUTEROL SULFATE 109 107 43 141
PREDNISONE 106 74 44 35
IBUPROFEN 104 74 45 89
CRESTOR 104 71 45 19
PANTOPRAZOLE SODIUM 97 93 47 36
CYCLOBENZAPRINE HCL 93 27 R 48 78
AMLODIPINE BESYLATE-BENAZEPRIL 91 90 49 77
POLYETHYLENE GLYCOL 3350 88 87 50 74
PRAVASTATIN SODIUM 86 78 51 16
ADVAIR DISKUS 86 59 51 45
VYTORIN 84 62 53 148
ALLOPURINOL 82 67 54 38
GLIMEPIRIDE 82 51 54 28
RAMIPRIL 81 76 56 81
MIRTAZAPINE 80 80 57 61
BENAZEPRIL HCL 80 62 57 108
RISPERIDONE 79 68 59 79
DIVALPROEX SODIUM 79 55 59 103
PROMETHAZINE HCL 78 15 R 61 106
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 73 62 31
LIPITOR 73 47 63 127
SPIRONOLACTONE 73 60 63 62
BENICAR HCT 69 51 65 179
FLUTICASONE PROPIONATE 68 47 66 44
LYRICA 66 51 67 67
SINGULAIR 66 37 67 60
ZETIA 65 62 69 59
AZITHROMYCIN 64 32 70 39
KLOR-CON M20 64 52 70 42
CLONIDINE HCL 63 60 72 50
PAROXETINE HCL 63 39 72 57
LANTUS 62 48 74 56
LOSARTAN-HYDROCHLOROTHIAZIDE 61 43 75 54
ALPRAZOLAM 61 49 75 128
COMBIVENT 60 49 77 117
FINASTERIDE 59 46 78 104
LEXAPRO 59 48 78 203
PHENYTOIN SODIUM EXTENDED 59 43 78 135
FENOFIBRATE 57 50 81 64
BYSTOLIC 53 33 82 114
AMITRIPTYLINE HCL 52 40 R 83 73
NOVOLIN R 52 51 83 247
MELOXICAM 50 46 85 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.